Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication
Résumé
We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).
Domaines
VirologieOrigine | Fichiers éditeurs autorisés sur une archive ouverte |
---|---|
Licence |